Wayne Marasco, MD, Allergy & Immunology, Boston, MA, Brigham and Women's Hospital

WayneAMarascoMD

Allergy & Immunology Boston, MA

Associate Professor of Medicine, Dana-Farber Cancer Institute

Are you Dr. Marasco?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 35 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Wayne Marasco, MD is an allergist/immunologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFELLOWSHIP
  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersRESIDENCY
  • University of Michigan Medical School
    University of Michigan Medical SchoolMEDICAL_SCHOOL

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1988 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Qatar’s Sidra Hospital Joins International Efforts to Develop COVID-19 Vaccine
    Qatar’s Sidra Hospital Joins International Efforts to Develop COVID-19 VaccineSeptember 09, 2020
  • Sidra Medicine Supports Safe Development of Covid-19 Vaccine
    Sidra Medicine Supports Safe Development of Covid-19 VaccineSeptember 08, 2020
  • Billionaire Patrick Soon-Shiong’s Radical Cancer Treatments Made Him One of the Wealthiest Physicians on Earth. Now the Master of Medical Marketing Believes His Drug Therapies Could Defeat “The Crisis of Our Time.”
    Billionaire Patrick Soon-Shiong’s Radical Cancer Treatments Made Him One of the Wealthiest Physicians on Earth. Now the Master of Medical Marketing Believes His Drug Therapies Could Defeat “The Crisis of Our Time.”August 27, 2020
  • Join now to see all

Grant Support

  • Study Of Broadly Neutralizing Antibody Generation To HIV Gp140 In Humanized MiceNational Institute Of Allergy And Infectious Diseases2010–2011
  • Broad Spectrum Neutralizing Human Abs To SARS And Related CoronavirusesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Spore Core 1: Administrative, Evaluation And PlanningNational Cancer Institute2009–2011
  • Human MAB Cocktails To Prevent &Treat H5N1 Avian InfluenzaNational Institute Of Allergy And Infectious Diseases2007–2011
  • Anti-Hiv-1 TAT Human SFV Intrabody Gene Therapy Against SHIV In Rhesus MacaquesNational Center For Research Resources2003–2011
  • Novel Vaginal Microbicides Based On Stable Aav-Neutralizing Antibody Gene TransfeNational Institute Of Allergy And Infectious Diseases2010
  • Novel Vaginal Microbicides Based On Stable Aav-Neutralizing Antibody Gene TransfeNational Institute Of Allergy And Infectious Diseases2008–2009
  • Generation Of A Therapeutic Antibody Directed Against CCR4 For Patients WithNational Cancer Institute2008
  • Studies Of CCR5 Conformational Heterogeneity &Hiv EntryNational Institute Of Allergy And Infectious Diseases2004–2008
  • Human Antibodies And Targeted Vaccines Against SARS-COVNational Institute Of Allergy And Infectious Diseases2004–2008
  • Role Of SHP-1 Deregulation In HTLV-1 LeukemogenesisNational Cancer Institute2004–2008
  • Human Anti-Macaque CCR5 Mabs For Passive ImmunotherapyNational Institute Of Allergy And Infectious Diseases2003–2007
  • Genetic Retargeted Human T-Cells For RCC ImmunotherapyNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • Anti-Hiv-1 TAT Human SFV Intrabody Gene TherapyNational Center For Research Resources2004
  • Targeting Human Cyclin T1 To Inhibit HIV-1 ReplicationNational Institute Of Allergy And Infectious Diseases2003–2004
  • Global Analysis Of Transcriptional Deregulation By HIV-1National Institute Of Allergy And Infectious Diseases2002–2003
  • Role Of Grb3-3 In T-Cell Activation &Hiv-1 ReplicationNational Institute Of Allergy And Infectious Diseases2001–2003
  • Intraceullular Anti-Tat Antibodies For AIDS Gene TherapyNational Institute Of Allergy And Infectious Diseases2000–2002
  • Gene Therapy By Phenotypic Knockout Of HIV CoreceptorsNational Institute Of Allergy And Infectious Diseases1998–2002
  • Human Antitat Intrabody Gene Therapy Against SHIVNational Center For Research Resources1999–2001
  • Intracellular Antitat Antibodies For AIDS Gene TherapyNational Institute Of Allergy And Infectious Diseases1995–1999
  • Gene Therapy Aids--A Recombinant Antibody-Based StrategyNational Institute Of Allergy And Infectious Diseases1994–1997
  • Repertoire Cloning Of Anti-Hiv-1 Gp120/Gp41 AntibodiesNational Institute Of Allergy And Infectious Diseases1993–1997
  • Mechanism Of Action Of The TAT Product Of HIV-1National Institute Of Allergy And Infectious Diseases1993
  • Cd23--Autocrine Growth Factor And ReceptorNational Cancer Institute1989–1991

Professional Memberships

Hospital Affiliations